Fundz

Onconova Therapeutics, Inc. reported raising $1.25 Million in an initial SEC Form D filing, from an offering of $1.25 Million

PUBLIC · TRAWJun 08, 2018

Amount Raised

$1.25 Million

$1.25 Million sold, per SEC Form D (first sale Jun 8, 2018)

Round Type

Seed

NewtownBiotechnology

Quick answer

Traws Pharma raised $1.25 Million in a Seed round, dated June 8, 2018. Traws Pharma is based in Newtown, Pennsylvania, United States.

How much did Traws Pharma raise?
Traws Pharma raised $1.25 Million in a Seed round on June 8, 2018.
What does Traws Pharma do?
Traws Pharma’s novel, proprietary, targeted multi-kinase CDK4/6 inhibitor narazaciclib is being evaluated in dose ranging Phase 1/2 clinical trials in patients with cancer, with or without co-administration of..
Where is Traws Pharma based and how big is it?
Traws Pharma is based in Newtown, Pennsylvania, United States.
Who are the decision-makers at Traws Pharma?
Fundz holds 3 contacts at Traws Pharma, including the Chief Science Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Traws Pharma that raised within 45 days of this round, from Fundz verified event records.

  • Bone Biologics raised $5.9M on July 23, 2018.
  • Avinger Inc raised $1.7M (Seed) on July 23, 2018.
  • Alpha Cognition raised $2M (Seed) on July 20, 2018.
  • Stemgenics, Inc. raised $445K (Seed) on July 20, 2018.
  • ZSX Medical, LLC raised $239K (Seed) on July 20, 2018.
  • AiVita Biomedical, Inc. raised $17M on July 20, 2018.

Who to call at Traws Pharma, and when

A new round usually means Traws Pharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Traws Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Traws Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Traws Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Traws Pharma

Location

12 Penns Trail

Newtown, Pennsylvania, United States

About

Traws Pharma’s novel, proprietary, targeted multi-kinase CDK4/6 inhibitor narazaciclib is being evaluated in dose ranging Phase 1/2 clinical trials in patients with cancer, with or without co-administration of letrozole, with the aim to define the recommended phase 2 dose for further development in endometrial cancer. Pre-clinically narazaciclib has shown efficacy in breast cancer cells resistant to palbociclib, assumed due to targeting proteins such as CSF-1 and FGFR implicated in resistance to these agents. Targeting ARK-5 (also known as NUAC 1) suggests additional tumors can be studied when high expression of these proteins are correlated with resistance.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Traws Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsC, Chief Science Officer hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Traws Pharma's next move

See what Strategic adds

Traws Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.